Crescent Biopharma (CBIO) Short-term Investments (2013 - 2017)
Crescent Biopharma (CBIO) posted quarterly Short-term Investments of $5219.0 for Q1 2017, down 24.46% year-over-year from $6909.0 in Q1 2016, and down 50.99% quarter-over-quarter from $10649.0 in Q4 2016.
Crescent Biopharma (CBIO) Short-term Investments (2013 - 2017) Analysis & Trends
Crescent Biopharma (CBIO) has reported Short-term Investments for 5 consecutive years, with $5219.0 the latest figure, recorded in Q1 2017.
- In Q1 2017, Short-term Investments fell 24.46% year-over-year to $5219.0; the TTM figure through Mar 2017 stood at $5219.0 (down 24.46% YoY), while the FY2016 annual figure was $10649.0, up 14.88% from the prior year.
- Short-term Investments fell to $5219.0 in Q1 2017 per CBIO's latest filing, from $10649.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $16293.0 in Q4 2014 and bottomed at $1000.0 in Q4 2013.
- Historically, Short-term Investments has averaged $8766.7 across 5 years, with a median of $9948.0 in 2015.
- Annual changes were most pronounced in 2014 — Short-term Investments jumped 1529.3% — and 2016, when it plunged 92.17%.
- Crescent Biopharma's Short-term Investments stood at $1000.0 in 2013, then surged by 1529.3% to $16293.0 in 2014, then sank by 43.1% to $9270.0 in 2015, then increased by 14.88% to $10649.0 in 2016, then plunged by 50.99% to $5219.0 in 2017.
- Business Quant data shows CBIO's Short-term Investments at $5219.0 in Q1 2017, $10649.0 in Q4 2016, and $1000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Crescent Biopharma | 1.10 Bn | 933.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 5,219.00 |
| Dec 31, 2016 | 10,649.00 |
| Jun 30, 2016 | 1,000.00 |
| Mar 31, 2016 | 6,909.00 |
| Dec 31, 2015 | 9,270.00 |
| Sep 30, 2015 | 10,626.00 |
| Jun 30, 2015 | 12,768.00 |
| Mar 31, 2015 | 13,933.00 |
| Dec 31, 2014 | 16,293.00 |
| Dec 31, 2013 | 1,000.00 |